{
  "ticker": "UBI",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972369",
  "id": "02972369",
  "pages": 6,
  "price_sensitive": true,
  "date": "20250724",
  "time": "1405",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250724/pdf/06m3f3qh196wqj.pdf",
  "summary": "### **Summary of Universal Biosensors, Inc. (ASX:UBI) \u2013 June 2025 Quarterly Report (Appendix 4C)**  \n\n#### **Financial Highlights**  \n- **Closing Cash Balance (30 June 2025):** **$2.55 million**  \n- **Net Cash Used in Operating Activities (Q2 2025):** **($2.13 million)** (improved from Q1 2025 by $1.59 million)  \n- **Government Grants Received:** **$2.20 million** (year-to-date)  \n- **Estimated Funding Runway:** **1.2 quarters** (based on current cash burn rate)  \n\n#### **Liquidity & Funding Status**  \n- **Secured Credit Facilities:** **$355k** (bank guarantees/security deposits)  \n- **Discussions Ongoing:** Exploring additional funding options (referenced in ASX release dated 2 July 2025)  \n\n#### **Operational Notes**  \n- **Key Markets:** Blood testing (Xprecia), wine testing (Sentia), water testing (Aquascout). No material updates on commercial traction.  \n\n#### **Material Risk**  \n- **Cash Shortfall Warning:** Operating runway <2 quarters; management expects to secure additional funding.",
  "usage": {
    "prompt_tokens": 3395,
    "completion_tokens": 262,
    "total_tokens": 3657,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-24T05:21:33.400115"
}